Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mesut Remzi

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
The Journal of Urology|June 16, 2012
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinomaMichael Rink, Brian D Robinson, David A Green, et al.
The Journal of Urology|October 30, 2012
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysisMorgan Rouprêt, Vincent Hupertan, Thomas Seisen, et al.
BJU International|November 8, 2008
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patientsMesut Remzi, Andrea Haitel, Vitaly Margulis, et al.
European Urology|December 5, 2009
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tractRichard Zigeuner, Shahrokh F Shariat, Vitaly Margulis, et al.
Urologic Oncology|December 22, 2019
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomyHsin-Chih Yeh, Vitaly Margulis, Nirmish Singla, et al.
BJU International|September 24, 2013
Predictors of survival in patients with disease recurrence after radical nephroureterectomyLuis A Kluth, Evanguelos Xylinas, Matthew Kent, et al.
European Urology|January 31, 2012
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinomaEugene K Cha, Shahrokh F Shariat, Matthias Kormaksson, et al.
Minerva Urology and Nephrology|January 13, 2021
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy SocietyGiancarlo Marra, Maria P Laguna, Jochen Walz, et al.
European Urology|November 23, 2019
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>†</sup>: Under the Auspices of the EAU-ESMO Guidelines CommitteesJ Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
European Urology|May 25, 2020
Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
The Journal of Urology|June 16, 2012
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinomaMichael Rink, Brian D Robinson, David A Green, et al.
The Journal of Urology|October 30, 2012
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysisMorgan Rouprêt, Vincent Hupertan, Thomas Seisen, et al.
BJU International|November 8, 2008
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patientsMesut Remzi, Andrea Haitel, Vitaly Margulis, et al.
European Urology|December 5, 2009
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tractRichard Zigeuner, Shahrokh F Shariat, Vitaly Margulis, et al.
Urologic Oncology|December 22, 2019
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomyHsin-Chih Yeh, Vitaly Margulis, Nirmish Singla, et al.
BJU International|September 24, 2013
Predictors of survival in patients with disease recurrence after radical nephroureterectomyLuis A Kluth, Evanguelos Xylinas, Matthew Kent, et al.
European Urology|January 31, 2012
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinomaEugene K Cha, Shahrokh F Shariat, Matthias Kormaksson, et al.
Minerva Urology and Nephrology|January 13, 2021
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy SocietyGiancarlo Marra, Maria P Laguna, Jochen Walz, et al.
European Urology|November 23, 2019
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>†</sup>: Under the Auspices of the EAU-ESMO Guidelines CommitteesJ Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
European Urology|May 25, 2020
Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]J Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
Pageof 17